2,000
Participants
Start Date
June 25, 2025
Primary Completion Date
February 20, 2027
Study Completion Date
May 12, 2027
REGN7508
Administered per the protocol
Apixaban
Administered per the protocol
Enoxaparin
Administered per the protocol
Placebo
Administered per the protocol
RECRUITING
Sinai Hospital of Baltimore, Inc., Baltimore
RECRUITING
Phoenix Clinical Research, Tamarac
RECRUITING
Gulfcoast Research Institute, Sarasota
RECRUITING
HD Research - First Surgical Hospital, Bellaire
RECRUITING
Flourish Research - San Antonio (Formerly Clinical Trials of Texas), San Antonio
RECRUITING
Denver Metro Orthopedics, P.C. Englewood Location, Englewood
RECRUITING
CARI Clinical Trials, Riverside
Regeneron Pharmaceuticals
INDUSTRY